{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:03:21Z","timestamp":1775217801393,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12328-026-02290-8","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:26:06Z","timestamp":1770791166000},"page":"451-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytomegalovirus gastritis following immune checkpoint inhibitor-associated gastritis induced by ipilimumab and nivolumab therapy in a patient with renal cell carcinoma"],"prefix":"10.1007","volume":"19","author":[{"given":"Nozomi","family":"Sano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Uraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0224-7093","authenticated-orcid":false,"given":"Satoru","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2290_CR1","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","volume":"36","author":"JR Brahmer","year":"2018","unstructured":"Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36:1714\u201368.","journal-title":"J Clin Oncol"},{"key":"2290_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3748\/wjg.v30.i14.1941","volume":"30","author":"J Lin","year":"2024","unstructured":"Lin J, Lin ZQ, Zheng SC, et al. Immune checkpoint inhibitor-associated gastritis: patterns and management. World J Gastroenterol. 2024;30:1941\u20138.","journal-title":"World J Gastroenterol"},{"key":"2290_CR3","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.3748\/wjg.v27.i41.7190","volume":"27","author":"K Yamada","year":"2021","unstructured":"Yamada K, Sawada T, Nakamura M, et al. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival. World J Gastroenterol. 2021;27:7190\u2013206.","journal-title":"World J Gastroenterol"},{"key":"2290_CR4","doi-asserted-by":"publisher","first-page":"e14151","DOI":"10.1200\/JCO.2019.37.15_suppl.e14151","volume":"37","author":"B Thapa","year":"2019","unstructured":"Thapa B, Roopkumar J, Kim AS, et al. Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI). J Clin Oncol. 2019;37:e14151\u2013e14151.","journal-title":"J Clin Oncol"},{"key":"2290_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/oncolo\/oyad031","volume":"28","author":"N Farha","year":"2023","unstructured":"Farha N, Faisal MS, Allende DS, et al. Characteristics of immune checkpoint inhibitor-associated gastritis: report from a major tertiary care center. Oncologist. 2023;28:706\u201313.","journal-title":"Oncologist"},{"key":"2290_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/cncr.34543","volume":"129","author":"A Haryal","year":"2023","unstructured":"Haryal A, Townsend MJ, Baskaran V, et al. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. Cancer. 2023;129:367\u201375.","journal-title":"Cancer"},{"key":"2290_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.14740\/gr1491","volume":"15","author":"M Alomari","year":"2022","unstructured":"Alomari M, Al Ashi S, Chadalavada P, et al. Gastrointestinal toxicities of immune checkpoint inhibitors are associated with enhanced tumor responsiveness and improved survival. Gastroenterol Res. 2022;15:56\u201366.","journal-title":"Gastroenterol Res"},{"key":"2290_CR8","volume":"10","author":"Y Sugiyama","year":"2022","unstructured":"Sugiyama Y, Tanabe H, Matsuya T, et al. Severe immune checkpoint inhibitor-associated gastritis: a case series and literature review. Endosc Int Open. 2022;10:E982-E989.","journal-title":"Endosc Int Open"},{"key":"2290_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/00365521.2019.1594356","volume":"54","author":"T Tang","year":"2019","unstructured":"Tang T, Abu-Sbeih H, Luo W, et al. Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors. Scand J Gastroenterol. 2019;54:538\u201345.","journal-title":"Scand J Gastroenterol"},{"key":"2290_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018927","volume":"99","author":"D Chen","year":"2020","unstructured":"Chen D, Zhao R, Cao W, et al. Clinical characteristics of cytomegalovirus gastritis: A retrospective study from a tertiary medical center. Medicine (Baltimore). 2020;99:e18927.","journal-title":"Medicine (Baltimore)"},{"key":"2290_CR11","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3748\/wjg.v16.i23.2907","volume":"16","author":"Y Kakugawa","year":"2010","unstructured":"Kakugawa Y, Kami M, Matsuda T, et al. Endoscopic diagnosis of cytomegalovirus gastritis after allogeneic hematopoietic stem cell transplantation. World J Gastroenterol. 2010;16:2907\u201312.","journal-title":"World J Gastroenterol"},{"key":"2290_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0160-6","volume":"6","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brahmer JR, Callahan MK, et al. Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers. 2020;6:38.","journal-title":"Nat Rev Dis Primers"},{"key":"2290_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","volume":"15","author":"HM Knochelmann","year":"2018","unstructured":"Knochelmann HM, Dwyer CJ, Bailey SR, et al. When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cell Mol Immunol. 2018;15:458\u201369.","journal-title":"Cell Mol Immunol"},{"key":"2290_CR14","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco LM, Salinas VH, Brown KE, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med. 2009;206:3015\u201329.","journal-title":"J Exp Med"},{"key":"2290_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/1756284819884196","volume":"12","author":"UN Shivaji","year":"2019","unstructured":"Shivaji UN, Jeffery L, Gui X, et al. Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management. Therap Adv Gastroenterol. 2019;12:1756284819884196.","journal-title":"Therap Adv Gastroenterol"},{"key":"2290_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/his.14029","volume":"76","author":"M Johncilla","year":"2020","unstructured":"Johncilla M, Grover S, Zhang X, et al. Morphological spectrum of immune check\u2010point inhibitor therapy\u2010associated gastritis. Histopathology. 2020;76:531\u20139.","journal-title":"Histopathology"},{"key":"2290_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5858\/arpa.2019-0700-OA","volume":"145","author":"L Irshaid","year":"2021","unstructured":"Irshaid L, Robert ME, Zhang XJ, et al. Immune checkpoint inhibitor-induced upper gastrointestinal tract inflammation shows morphologic similarities to, but is immunologically distinct from, helicobacter pylori gastritis and celiac disease. Arch Pathol Lab Med. 2021;145:191\u2013200.","journal-title":"Arch Pathol Lab Med"},{"key":"2290_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00428-018-2454-6","volume":"473","author":"H El-Zimaity","year":"2018","unstructured":"El-Zimaity H, Choi W-T, Lauwers GY, et al. The differential diagnosis of Helicobacter pylori negative gastritis. Virchows Arch. 2018;473:533\u201350.","journal-title":"Virchows Arch"},{"key":"2290_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejca.2017.09.019","volume":"86","author":"C Franklin","year":"2017","unstructured":"Franklin C, Rooms I, Fiedler M, et al. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis. Eur J Cancer. 2017;86:248\u201356.","journal-title":"Eur J Cancer"},{"key":"2290_CR20","volume":"41","author":"M Nakai","year":"2022","unstructured":"Nakai M, Kai Y, Suzuki K, et al. A case of perforated immune-related colitis complicated by cytomegalovirus infection during treatment of immune-related adverse effect in lung cancer immunotherapy. Respir Med Case Rep. 2022;41:101794.","journal-title":"Respir Med Case Rep"},{"key":"2290_CR21","first-page":"33","volume":"10","author":"Y Amino","year":"2021","unstructured":"Amino Y, Uematsu S, Yoshizawa T, et al. A case involving careful control of cytomegalovirus infection during immunosuppressive therapy for severe immune-related adverse events caused by nivolumab. AJRS. 2021;10:33\u20136.","journal-title":"AJRS"},{"key":"2290_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2957\/kanzo.63.107","volume":"63","author":"T Tadokoro","year":"2022","unstructured":"Tadokoro T, Tani J, Takamura K, et al. Clinical features of hepatic dysfunction caused by immune checkpoint inhibitors and treatment of refractory cases. Kanzo. 2022;63:107\u201319.","journal-title":"Kanzo"},{"key":"2290_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2141.2009.07714.x","volume":"146","author":"D DiMaggio","year":"2009","unstructured":"DiMaggio D, Anderson A, Bussel JB. Cytomegalovirus can make immune thrombocytopenic purpura refractory. Br J Haematol. 2009;146:104\u201312.","journal-title":"Br J Haematol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02290-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02290-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02290-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:25:06Z","timestamp":1775215506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02290-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2290"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02290-8","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}